Sulabha Ranganathan

Sulabha Ranganathan has an extensive work experience in the field of clinical research. Sulabha currently holds the position of Executive Director of Clinical Research at Shattuck Labs. Prior to this, they worked at Incyte as the Executive Director and later as the Senior Director of Clinical Research Scientist. Sulabha also served as the Director of Clinical Science and Operations at Adaptimmune and as the Director of Clinical Development at Novartis Pharmaceuticals. Additionally, they held various positions at GlaxoSmithKline, including Director of Oncology Clinical and Operational Sciences. Sulabha began their career as an Assistant Director at Wyeth and worked as a Post-doctoral associate, Senior Scientist, and Translational Research Facility Director at Fox Chase Cancer Center.

Sulabha Ranganathan completed their Master of Science (MSc) in Biosciences from Andhra University between 1978 and 1980. Sulabha then pursued a MS and PhD in Biology, Toxicology, and Teratology from The University of Alabama, which they completed between 1982 and 1988.